Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.

Caraglia, M; Marra, M; Tagliaferri, P; Lamberts, S W J; Zappavigna, S; Misso, G; Cavagnini, F; Facchini, G; Abbruzzese, A; Hofland, L J; Vitale, G

Caraglia, M; Marra, M; Tagliaferri, P; Lamberts, S W J; Zappavigna, S; Misso, G; Cavagnini, F; Facchini, G; Abbruzzese, A; Hofland, L J; Vitale, G.

Affiliation

Caraglia M; Department of Biochemistry and Biophysics, II University of Naples, 80138, Naples, Italy. Michele.Caraglia@unina2.it

Curr Cancer Drug Targets ; 9(5): 690-704, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19508175

Subject(s)

Antineoplastic Agents/pharmacology; Cell Survival/drug effects; Interferon Type I/metabolism; Interferon Type I/pharmacology; Apoptosis/drug effects; Apoptosis/physiology; Forecasting; Gene Expression Regulation/drug effects; Humans; Interferon Type I/therapeutic use; Models, Biological; Neoplasms/drug therapy; Protein Processing, Post-Translational/drug effects; Signal Transduction/drug effects; Signal Transduction/physiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Cell Survival / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Cancer Drug Targets Year: 2009 Document type: Article

Search on Google

XML

PubMed Links